LAUSR

Gastric cancer is still a major cancer worldwide and more than one million cases of gastric cancer are diagnosed each year. It is known that stomach cancer is increasing, especially after surgical interventions to the stomach. Due to obesity and diabetes, the most common diseases of our age, obesity and metabolic surgery have been performed widely in recent years. Here in, It is aimed to report an interesting case of gastric cancer located on the stapler line in a short time after Sleeve Gastrectomy with Transit Bipartition operation. A 60-year-old male patient consulted to the general surgery outpatient clinic with complaints of intermittent epigastric pain and bloating. Sleeve Gastrectomy with Transit Bipartition operation was performed 3 years ago for morbid obesity and Type 2 diabetes. During endoscopy, a mucosal irregularity was detected in the gastric corpus. Histopathological examination of the biopsies revealed mucinous adenocarcinoma (signet ring cell type). Total gastrectomy was performed and the patient was discharged without any problem. We conducted a literature review of the studies published in English on PubMed, Medline and Google Scholarly databases on the development of cancer after Sleeve Gastrectomy with Transit Bipartition operation. Although we found many cases with gastric cancer in the follow-up only after Sleeve Gastrectomy, we did not find any cancer in the follow-up after Sleeve Gastrectomy with Transit Bipartition operation. Due to this feature, this case is the first case reported in the literature. In the postoperative follow-up of patients who have undergone Sleeve Gastrectomy with Transit Bipartition operation, we should be careful about gastric cancer, and we should not refrain from examination on the slightest suspicion.